SI Joint Compression Management
For sacroiliac joint pain, begin with conservative management (physical therapy, NSAIDs) for at least one month, then proceed to fluoroscopically-guided intra-articular corticosteroid injections if 3 or more provocative maneuvers are positive, reserving radiofrequency ablation or surgical fusion only for patients who fail injections.
Diagnostic Approach
The physical examination is your primary diagnostic tool. You need 3 out of 6 provocative maneuvers positive (Patrick's Test, Thigh Thrust, Gaenslen's Test, Distraction, Compression, Sacral Thrust) to achieve 94% sensitivity and 78% specificity for SI joint pain 1. With only 1-2 positive tests, specificity drops to 44-66%, making successful treatment less likely 1.
Key caveat: In patients with predisposing factors (pelvic trauma, spondyloarthropathy, prior L5-S1 fusion), you can proceed with only 1-2 positive maneuvers due to higher disease prevalence in these populations 1.
Imaging adds minimal diagnostic value unless inflammatory spondyloarthropathy is suspected 1.
Treatment Algorithm
First-Line: Conservative Management (Minimum 1 Month)
- Over-the-counter NSAIDs
- Physical therapy and exercise
- Manual medicine techniques
- Pain intensity should be >4/10 and duration >1 month before escalating 1
Exception: You may proceed earlier if pain causes significant functional limitation despite conservative trials 1.
Second-Line: Fluoroscopically-Guided Corticosteroid Injections
Critical point: Palpation-guided injections have poor accuracy and should never be used 1. Fluoroscopy is mandatory as it confirms intra-articular placement and rules out intravascular positioning 1.
The evidence for corticosteroid injections shows short-term benefit (up to 3 months) in some patients 2. Consider repeat injection if:
- ≥75% relief from initial diagnostic local anesthetic injection, OR
- ≥50% relief lasting ≥2 months from first steroid injection 1
Emerging evidence: Combined intra-articular and extra-articular injections may provide superior benefit compared to intra-articular alone 1.
Third-Line: Radiofrequency Ablation
Here's where guidelines dramatically diverge: The 2025 BMJ guideline reveals complete inconsistency across major societies 3. The 2022 ASPN gives a "strong recommendation" for SI joint denervation, while 2020 NICE guidelines are more restrictive 3.
Despite guideline conflicts, the clinical evidence supports radiofrequency ablation (RFA) of L5 dorsal ramus and S1-3 lateral branches when injections fail 2. Cooled RFA demonstrates the strongest evidence with extensive lesioning strategies 2. Both continuous and pulsatile RFA show good outcomes 4.
Fourth-Line: Surgical Fusion
Reserved exclusively for patients failing all conservative and interventional options 5, 4. Multiple fusion techniques exist, though optimal methodology remains debated 4.
Safety Profile
SI joint injections are generally safe 1. Common adverse events include:
- Injection site soreness (most common)
- Vasovagal reactions (2.5% incidence) 1
- Facial flushing/sweating (steroid-specific)
- Transient sciatic nerve block (if local anesthetic used)
- Pain exacerbation
Anticoagulation can typically be continued as bleeding risk is low 1. Serious complications (infection, epidural abscess) are rare 1.
Critical Pitfalls
The 2025 BMJ guideline highlights a major problem: positive results for interventional procedures are three times more likely when authored by interventionalists versus non-interventionalists 3. This publication bias means you must critically evaluate the evidence quality.
The most important pitfall: Neither history nor physical examination alone reliably diagnoses SI joint pain 1. The current clinical standard requires image-guided intra-articular anesthetic injection response, but even this has limitations 1.
Evidence Quality Context
The 2025 BMJ guideline concludes there is "no consistency in recommendations for or against any interventional procedure" for spine pain 3. The 2022 ASPN gives strong recommendations favoring SI joint injections and ablation, while 2021 ACOEM and 2020 NICE are more restrictive 3. This reflects the moderate-to-low quality evidence base and specialty-specific biases.
Given this uncertainty, the conservative-to-invasive stepwise approach prioritizes patient safety while offering therapeutic options when conservative management fails.